Cure My Disease
Don't miss your cure!
Clinical trials sponsored by Immorna Biotherapeutics, Inc., explained in plain language.
This early-stage study tests an experimental mRNA vaccine called JCXH-108 for preventing respiratory syncytial virus (RSV) infection. About 75 healthy adults aged 18-45 or 60 and older will receive either the vaccine or a placebo. Researchers will monitor side effects and measure…
Phase: PHASE1 • Sponsor: Immorna Biotherapeutics, Inc. • Aim: ⭐️ VACCINE ⭐️
Last updated May 01, 2026 21:27 UTC